Marker Therapeutics, Inc. (MRKR)

Marker Therapeutics Revenue

Marker Therapeutics had revenue of $751.69K in the quarter ending March 31, 2026, with 115.32% growth. This brings the company's revenue in the last twelve months to $3.20M, down -43.86% year-over-year. In the year 2025, Marker Therapeutics had annual revenue of $3.55M, down -46.19%.

• Revenue (ttm): $3.20M
• Revenue Growth: -43.86%
• P/S Ratio: 6.91
• Revenue / Employee: $709,334
• Employees: 5
• Market Cap: 24.68M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.55M	-3.04M	-46.19%
Dec 31, 2024	6.59M	3.28M	99.06%
Dec 31, 2023	3.31M	-5.70M	-63.26%
Dec 31, 2022	9.01M	7.77M	625.90%
Dec 31, 2021	1.24M	774.93K	166.01%
Dec 31, 2020	466.79K	253.59K	118.95%
Dec 31, 2019	213.19K	7.20K	3.50%
Dec 31, 2018	205.99K	22.93K	12.53%
Dec 31, 2017	183.06K	-48.14K	-20.82%
Dec 31, 2016	231.20K	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	-	-	-
Dec 31, 2010	-	-	-
Dec 31, 2009	-	-	-
Dec 31, 2008	-	-	-
Dec 31, 2007	-	-	-

Data Source: Fiscal.ai Last updated: May 15, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 27, 2026

Data Sources Report a data error